​

 

9h15 : Stéphanie GERMON - Opening speech 

 

Part I : Autoimmune diseases, causes and mechanisms

​

9h30 - 10h :  PhD. Mathias LAVIE-RICHARD - Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients - INRAE,  Jouy-en-Josas, France

 

10h10 - 10h40  : PhD, Assistant Professor Marvin VAN LUIJN - Deciphering the programs of B and T cells driving multiple sclerosis - Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.

 

10h40 - 10h50  : Poster 1 : Microbiota, Dysbiosis and Autoimmune Diseases

 

10H50 - 11h10 : Break

 

11h10 - 11h40 : Pr. Didier HOBER - Enteroviral pathogenesis of type 1 diabetes - Laboratoire de virologie ULR3610 Université de Lille & CHU Lille, Lille, France

 

11h50 - 12h20 : Pr. Jean ROUDIER - What remains of the role of Epstein-Barr virus in Rheumatoid arthritis  - INSERM UMRs1097, Marseille, France.

 

12h20 - 12h30 : Poster 2 : Hepatitis and autoimmune diseases  

 

12h30 -14h00 : Lunch Break 

 

Part II : Autoimmune diseases main treatments 

 

14h -14h30 : PhD. Florence VELGE-ROUSSEL - In vitro effects of new bispecific antibodies targeting dendritic cells recruited during rheumatoid arthritis - UMR/CNRS 7292 GICC, Tours, France

 

14h40 - 15h10 : Pr. Benjamin PARIENTE - Ustekinumab for Crohn's Disease - CHRU/Inserm 995, Université Lille-II, Lille, FRANCE 

 

15h10 - 15h20 :  Poster 3 : Helminthes as a therapeutic strategy for autoimmune diseases 

 

​

15h20 - 15h40 : Break

​

15h40 - 15h55 : MD. Chantal MATHIEU - Type 1 diabetes, Immunotherapy - Chair of Endocrinology, Katholieke Universiteit Leuven, Belgium

​

16h05 - 16h25 : Poster 4 : SARS-Cov-2 and Autoimmune Diseases

​

16h30 : End speech